Total Payments
$5,404
2024 Payments
$972.68
Companies
25
Transactions
257
Medicare Patients
6,236
Medicare Billing
$511,326
Payment Breakdown by Category
Food & Beverage$5,380 (99.6%)
Education$23.86 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,380 | 254 | 99.6% |
| Education | $23.86 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,658 | 77 | $0 (2024) |
| LEO Pharma Inc. | $611.75 | 33 | $0 (2022) |
| Lilly USA, LLC | $469.14 | 20 | $0 (2024) |
| GENZYME CORPORATION | $245.44 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $233.17 | 12 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $228.08 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $223.26 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $222.59 | 10 | $0 (2024) |
| PFIZER INC. | $209.89 | 12 | $0 (2024) |
| Celgene Corporation | $208.81 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $972.68 | 44 | ABBVIE INC. ($320.48) |
| 2023 | $901.31 | 39 | AbbVie Inc. ($284.19) |
| 2022 | $835.37 | 40 | ABBVIE INC. ($305.76) |
| 2021 | $863.13 | 43 | AbbVie Inc. ($266.82) |
| 2020 | $396.52 | 18 | AbbVie Inc. ($209.62) |
| 2019 | $325.96 | 16 | AbbVie, Inc. ($94.92) |
| 2018 | $632.85 | 32 | AbbVie, Inc. ($109.54) |
| 2017 | $476.16 | 25 | AbbVie, Inc. ($66.74) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.94 | General |
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: Immunology | ||||||
| 09/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Immunology | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: DERMATOLOGY | ||||||
| 08/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: DERMATOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.55 | General |
| Category: Immunology | ||||||
| 07/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Immunology | ||||||
| 06/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: DERMATOLOGY | ||||||
| 06/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Dermatology | ||||||
| 05/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Dermatology | ||||||
| 05/16/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Immunology | ||||||
| 05/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Immunology | ||||||
| 05/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.39 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,650 | 4,074 | $603,849 | $122,017 |
| 2022 | 19 | 1,519 | 4,264 | $604,195 | $121,870 |
| 2021 | 24 | 1,595 | 3,219 | $685,684 | $163,632 |
| 2020 | 19 | 1,472 | 2,393 | $392,785 | $103,807 |
Total Patients
6,236
Total Services
13,950
Medicare Billing
$511,326
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 369 | 583 | $178,398 | $41,185 | 23.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 511 | 831 | $114,436 | $25,208 | 22.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 103 | 119 | $50,337 | $10,086 | 20.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 141 | 198 | $60,588 | $9,554 | 15.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 45 | 61 | $27,755 | $6,146 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 77 | 77 | $32,571 | $6,075 | 18.7% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 17 | 1,281 | $42,273 | $5,933 | 14.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 100 | 576 | $22,464 | $3,441 | 15.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 20 | $12,740 | $2,767 | 21.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $8,450 | $2,032 | 24.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 36 | $9,360 | $1,652 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 19 | $8,037 | $1,579 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 30 | $6,060 | $1,403 | 23.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 38 | 49 | $4,802 | $1,090 | 22.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 36 | 36 | $5,508 | $1,019 | 18.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 21 | $4,914 | $933.16 | 19.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 40 | 40 | $4,440 | $825.63 | 18.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 12 | 24 | $7,800 | $769.34 | 9.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 31 | 32 | $1,600 | $295.42 | 18.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 28 | $1,316 | $22.71 | 1.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 335 | 540 | $165,240 | $37,676 | 22.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 491 | 790 | $109,144 | $24,576 | 22.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 101 | 119 | $50,337 | $10,199 | 20.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 140 | 203 | $62,118 | $10,046 | 16.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $30,879 | $6,148 | 19.9% |
About Dr. Deon Wolpowitz, MD
Dr. Deon Wolpowitz, MD is a Dermatopathology healthcare provider based in Wellesley Hills, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396753307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deon Wolpowitz, MD has received a total of $5,404 in payments from pharmaceutical and medical device companies, with $972.68 received in 2024. These payments were reported across 257 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,380).
As a Medicare-enrolled provider, Wolpowitz has provided services to 6,236 Medicare beneficiaries, totaling 13,950 services with total Medicare billing of $511,326. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Wellesley Hills, MA
- Active Since 08/04/2006
- Last Updated 10/28/2024
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1396753307
Products in Payments
- SKYRIZI (Biological) $591.48
- RINVOQ (Biological) $541.17
- TALTZ (Drug) $423.75
- ENSTILAR (Drug) $421.67
- DUPIXENT (Biological) $281.56
- Humira (Biological) $271.20
- Sotyktu (Drug) $223.26
- HUMIRA (Biological) $214.77
- EUCRISA (Drug) $209.89
- COSENTYX (Biological) $202.99
- ADBRY (Biological) $172.36
- DUPIXENT (Drug) $134.77
- Cimzia (Drug) $123.73
- OPZELURA (Drug) $108.93
- ILUMYA (Biological) $88.84
- TREMFYA (Drug) $82.58
- VTAMA (Drug) $82.15
- Winlevi (Drug) $80.68
- Otezla (Drug) $66.53
- Zoryve (Drug) $65.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.